Founded in 2023 by Yale scientists, Revalia Bio is a high-growth startup addressing a structural gap in drug and device development: the lack of scalable human-relevant data.
To fill this gap, Revalia has developed a first-of-its-kind integrated data system designed to capture and structure high-fidelity human biological data. Revalia's studies are conducted using revived donated human organs and generate insights that help inform development decisions across research and clinical programs.
Founded on the premise of ethical donor stewardship, Revalia's mission is to honor the legacy of every organ donor by turning the loss of one life into knowledge that shapes the future of medicine.
We have proudly been generating revenue from day one, and today our mission is backed by $20M in venture funding and $30M in government contracts. Revalia is also an ARPA-H award winner and is backed by some of the most forward-thinking institutions.
Our company includes an accomplished, diverse team of scientists, clinicians, and developers from organizations such as Johnson & Johnson, Amazon, Google, and more.
We attract team members who aren't satisfied with the status quo in drug and device development. They are patient-focused individuals, passionate about being part of something no one else has done.
We earn the trust of our partners, donors, and each other through radical transparency and unwavering integrity.
Science and business are unpredictable. We stay flexible, iterate fast, and never stop learning.
The problems we solve are hard by design. We push through when others give up.
The best outcomes come from diverse perspectives working together toward a shared goal.
We're not building another app. We're transforming how humanity develops drugs — with implications for millions of patients.
Work with human organ data, cutting-edge perfusion technology, and purpose-built software that has never existed before.
Learn from Yale faculty, former J&J executives, Amazon leaders, and Cambridge transplant surgeons — all united around one mission.
Senior leader building and scaling Revalia's clinical operations infrastructure across multiple sites for Human Data Trials, including perfusion execution, SOPs, staffing strategy, and OPO partnerships.
Oversees daily operations of the Data Generation Laboratory including workflows, inventory, equipment maintenance, and sample management to support Human Data Trials research.
Customer-centric program manager driving successful delivery of Human Data Trial programs in partnership with customers and cross-functional scientific, operational, and commercial teams.
Group Product Manager – Growth driving 0-to-1 product development and growth strategies for research software products serving biotech and pharmaceutical customers.
PhD-level scientist-engineer shaping Revalia's biomarker discovery, physiological modeling, hardware-integrated sensing, and data platform strategy across pharma, devices, and ML integration.
Ready to accelerate your next program? Schedule a meeting with our team to explore how Human Data Trials can transform your pipeline.